CTT aims to contribute to a better health for all by providing state-of-the-art medical solutions to medicinal difficulties such as chronic ulcers, non-healing wounds, severe burns and skin losses. The constantly growing demand of gold standard in aesthetic market is what motivated CTT to also come up with the autologous aesthetic solution. The target is to provide safe and effective alternative to the aesthetic/cosmetic market, which is full of health hazardous products.
This is founded on the commitment and expertise as a Malaysian pioneer of medical excellence in the field of Tissue Engineering and Regenerative Medicine. We have been at the forefront of the country's modern medicine's most remarkable discoveries with our latest product, MyDerm® - an innovative bilayered-3D-autologous skin substitute which is the latest in Tissue Engineering technology. Clinically proven to boost wound healing and tremendously improve surgical outcome, MyDerm® is developed to become the ultimate alternative for conventional surgical skin substitute methods.
CTT also provides research grade cells and tissue to support cell and tissue based research and thus aims to contribute to the advancement of Tissue Engineering in Malaysia.
We strive in our mission:-
We are progressively aiming to become one of the fastest growing corporate companies in Malaysia. This includes building up our clients' base and portfolio by offering excellence commitment and believing strongly in our capabilities in providing the best possible products and services that can benefit people all over.
This is founded on the commitment and expertise as a Malaysian pioneer of medical excellence in the field of Tissue Engineering and Regenerative Medicine. We have been at the forefront of the country's modern medicine's most remarkable discoveries with our latest product, MyDerm® - an innovative bilayered-3D-autologous skin substitute which is the latest in Tissue Engineering technology. Clinically proven to boost wound healing and tremendously improve surgical outcome, MyDerm® is developed to become the ultimate alternative for conventional surgical skin substitute methods.
CTT also provides research grade cells and tissue to support cell and tissue based research and thus aims to contribute to the advancement of Tissue Engineering in Malaysia.
We strive in our mission:-
- To provide solutions to various medical problems by commercializing breakthrough medical technology to be benefited by all.
- To promote Malaysia as a capable, competitive and recognized medical contributor on par with any other recognized international medical and pharmaceutical companies.
- To brand Malaysia as an outstanding model for medical breakthroughs and innovation in tissue engineering research so that we are known as the "Tissue Engineering Hub” in this region.
- To make Tissue Engineering research more reachable and affordable for academic and commercial institutes.
We are progressively aiming to become one of the fastest growing corporate companies in Malaysia. This includes building up our clients' base and portfolio by offering excellence commitment and believing strongly in our capabilities in providing the best possible products and services that can benefit people all over.
